Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category, whereas...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical manifestations of dual-gene variants in retinitis pigmentosa.

Acta ophthalmologica·2026
Same author

High-Density Lipoprotein Nanoparticles Delivering Liver X Receptor Agonist for the Treatment of Age-Related Macular Degeneration.

Molecular pharmaceutics·2026
Same author

Blood mtDNA markers of mitochondrial subtype and early-onset Parkinson's disease biology.

Brain : a journal of neurology·2026
Same author

Identification of Brimonidine as a Novel Substrate of Organic Cation Transporters OCT2 and MATE1 Expressed in Human Eye.

Investigative ophthalmology & visual science·2026
Same author

Decline of Visual Function and Risk of Legal Blindness With Age in RPGR -Associated Retinal Degeneration: A Multicenter Study.

Clinical & experimental ophthalmology·2026
Same author

De novo and inherited dominant variants in U4 and U6 snRNA genes cause retinitis pigmentosa.

Nature genetics·2026

Related Experiment Video

Updated: May 8, 2026

Quantitative Fundus Autofluorescence for the Evaluation of Retinal Diseases
07:22

Quantitative Fundus Autofluorescence for the Evaluation of Retinal Diseases

Published on: March 11, 2016

Diagnostic fundus autofluorescence patterns in achromatopsia.

Abigail T Fahim1, Naheed W Khan, Sarwar Zahid

  • 1Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, Michigan.

American Journal of Ophthalmology
|August 27, 2013
PubMed
Summary

Fundus autofluorescence (FAF) reveals early foveal hyperfluorescence in achromatopsia patients, progressing to hypofluorescence with age. These diagnostic patterns correlate with optical coherence tomography (OCT) findings of foveal atrophy.

More Related Videos

A Workflow to Quantitatively Determine Age-Related Macular Degeneration Lesion-Specific Variations in Fundus Autofluorescence
08:54

A Workflow to Quantitatively Determine Age-Related Macular Degeneration Lesion-Specific Variations in Fundus Autofluorescence

Published on: May 26, 2023

Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
10:14

Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Published on: May 26, 2023

Related Experiment Videos

Last Updated: May 8, 2026

Quantitative Fundus Autofluorescence for the Evaluation of Retinal Diseases
07:22

Quantitative Fundus Autofluorescence for the Evaluation of Retinal Diseases

Published on: March 11, 2016

A Workflow to Quantitatively Determine Age-Related Macular Degeneration Lesion-Specific Variations in Fundus Autofluorescence
08:54

A Workflow to Quantitatively Determine Age-Related Macular Degeneration Lesion-Specific Variations in Fundus Autofluorescence

Published on: May 26, 2023

Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
10:14

Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Published on: May 26, 2023

Area of Science:

  • Ophthalmology
  • Medical Imaging
  • Genetics

Background:

  • Achromatopsia is a rare inherited retinal disorder characterized by reduced visual acuity, photophobia, and color vision deficits.
  • Diagnostic imaging modalities like fundus autofluorescence (FAF) and optical coherence tomography (OCT) are crucial for understanding retinal diseases.

Purpose of the Study:

  • To characterize the distinct fundus autofluorescence (FAF) patterns observed in patients diagnosed with achromatopsia.
  • To correlate these FAF findings with corresponding optical coherence tomography (OCT) features.

Main Methods:

  • An observational case series was conducted involving 10 patients with achromatopsia.
  • Evaluations included best-corrected visual acuity, ophthalmoscopy, Goldmann visual field testing, full-field electroretinography (ffERG), OCT, and FAF photography.
  • FAF patterns were analyzed in relation to patient age and foveal structural changes seen on OCT.

Main Results:

  • Patients were categorized into two age groups: younger (11-23 years) and older (52-63 years).
  • All patients exhibited significantly diminished photopic ffERG responses.
  • Younger patients showed minimal foveal atrophy on OCT and presented with foveal and parafoveal hyperfluorescence on FAF, an early sign also noted in an infant with CNGA3 mutations.
  • Older patients displayed advanced foveal atrophy with hypofluorescence and cavitation on OCT, correlating with punched-out hypofluorescent areas on FAF.

Conclusions:

  • Foveal hyperfluorescence on FAF serves as an early indicator for achromatopsia, aiding clinical diagnosis.
  • Age-dependent alterations in FAF patterns were observed, suggesting disease progression.
  • These FAF findings correlate with foveal atrophy and cavitation on OCT, offering potential for disease monitoring and defining therapeutic windows.